MBX Biosciences Q1 EPS $(0.51) Beats $(0.61) Estimate
Benzinga Newsdesk 5 months ago
EarningsEarnings BeatsNews
MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.61) by 16.39 percent. This is a 28.17 percent increase over losses of $(0.71) per share from
MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.61) by 16.39 percent. This is a 28.17 percent increase over losses of $(0.71) per share from the same period last year.